Subject(s)
Goals , Leadership , Public Policy/legislation & jurisprudence , Science/legislation & jurisprudence , Science/organization & administration , Technology/legislation & jurisprudence , Technology/organization & administration , China , Climate Change , Competitive Behavior , Cooperative Behavior , European Union , Humans , Pandemics , Politics , Public Policy/economics , Public Policy/trends , Public-Private Sector Partnerships , Science/economics , Science/trends , Social Sciences , Technology/economics , Technology/trends , United StatesABSTRACT
This year's Lasker-Bloomberg Public Service Award goes to GAVI, the Vaccine Alliance, for providing sustained access to childhood vaccines around the globe, saving millions of lives, and highlighting the power of immunization to prevent disease.
Subject(s)
International Cooperation , Vaccination/economics , Vaccination/history , Vaccines/history , Vaccines/supply & distribution , Child , Global Health , History, 17th Century , History, 18th Century , History, 19th Century , History, 20th Century , History, 21st Century , Humans , Immunization Programs , Investments , Poverty , Preventive Medicine/methods , Vaccines/economicsSubject(s)
Career Choice , Government , Industry , Radiologists , Universities , Algeria , Humans , National Institutes of Health (U.S.) , United StatesABSTRACT
Importance: Recent discussion has focused on questions related to the repeal and replacement of portions of the Affordable Care Act (ACA). However, issues central to the future of health and health care in the United States transcend the ACA provisions receiving the greatest attention. Initiatives directed to certain strategic and infrastructure priorities are vital to achieve better health at lower cost. Objectives: To review the most salient health challenges and opportunities facing the United States, to identify practical and achievable priorities essential to health progress, and to present policy initiatives critical to the nation's health and fiscal integrity. Evidence Review: Qualitative synthesis of 19 National Academy of Medicine-commissioned white papers, with supplemental review and analysis of publicly available data and published research findings. Findings: The US health system faces major challenges. Health care costs remain high at $3.2 trillion spent annually, of which an estimated 30% is related to waste, inefficiencies, and excessive prices; health disparities are persistent and worsening; and the health and financial burdens of chronic illness and disability are straining families and communities. Concurrently, promising opportunities and knowledge to achieve change exist. Across the 19 discussion papers examined, 8 crosscutting policy directions were identified as vital to the nation's health and fiscal future, including 4 action priorities and 4 essential infrastructure needs. The action priorities-pay for value, empower people, activate communities, and connect care-recurred across the articles as direct and strategic opportunities to advance a more efficient, equitable, and patient- and community-focused health system. The essential infrastructure needs-measure what matters most, modernize skills, accelerate real-world evidence, and advance science-were the most commonly cited foundational elements to ensure progress. Conclusions and Relevance: The action priorities and essential infrastructure needs represent major opportunities to improve health outcomes and increase efficiency and value in the health system. As the new US administration and Congress chart the future of health and health care for the United States, and as health leaders across the country contemplate future directions for their programs and initiatives, their leadership and strategic investment in these priorities will be essential for achieving significant progress.
Subject(s)
Community Participation , Delivery of Health Care/organization & administration , Health Care Costs , Health Priorities , National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division , Power, Psychological , Biomedical Research , Evidence-Based Medicine , Health Facilities , Health Personnel/education , Healthcare Disparities , Humans , Reimbursement, Incentive , United StatesSubject(s)
Internationality , Public Health , Social Control, Formal , Drug and Narcotic Control , HumansABSTRACT
Without a step change in the productivity of pharmaceutical research and development, it will be difficult to tackle the public health challenges facing societies worldwide. Publicprivate partnerships could play a key role in achieving this step change, but they need to be well designed and led.
Subject(s)
Biomedical Research/methods , Cooperative Behavior , Drug Discovery/methods , Public-Private Sector Partnerships , Drug Industry , Humans , Public Health/methodsABSTRACT
In the face of poorly understood disease complexity, a diversity of approaches is the best strategy.
Subject(s)
Drug Discovery , Translational Research, Biomedical , Animals , HumansSubject(s)
Drug Discovery , Translational Research, Biomedical , Animals , Clinical Trials as Topic , Drug Industry/economics , Humans , Molecular Targeted Therapy , Proprotein Convertase 9 , Proprotein Convertases/genetics , Proprotein Convertases/metabolism , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolismSubject(s)
Biological Science Disciplines/organization & administration , Biotechnology/organization & administration , Drug Industry/organization & administration , Investments/organization & administration , Translational Research, Biomedical/organization & administration , Universities/organization & administration , Interinstitutional Relations , United StatesSubject(s)
Radiology/history , Societies, Medical/history , History, 21st Century , Humans , North AmericaABSTRACT
Neglected tropical diseases (NTDs) represent a major health burden in many developing countries. To date, global efforts to control thirteen parasitic and bacterial infections that affect more than 1.4 billion people have relied on mass drug administration. This singular approach should now be expanded to a more comprehensive suite of tools including coordinated community-based programs, vector control, local training, education, and environmental change. In addition, an intensive basic research agenda is urgently needed to develop effective diagnostic, preventive, and therapeutic interventions to stay one step ahead of the evolutionary adaptation tactics of disease-causing microbes and parasites.